Élie Azria

ORCID: 0000-0002-6159-6253
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Maternal and Perinatal Health Interventions
  • Maternal and fetal healthcare
  • Global Maternal and Child Health
  • Assisted Reproductive Technology and Twin Pregnancy
  • Pregnancy-related medical research
  • Pregnancy and preeclampsia studies
  • Healthcare Systems and Practices
  • Migration, Health and Trauma
  • Neonatal Respiratory Health Research
  • Health, Medicine and Society
  • Prenatal Screening and Diagnostics
  • Preterm Birth and Chorioamnionitis
  • HIV/AIDS Research and Interventions
  • Maternal Mental Health During Pregnancy and Postpartum
  • Gestational Diabetes Research and Management
  • Ectopic Pregnancy Diagnosis and Management
  • Birth, Development, and Health
  • Cardiovascular Issues in Pregnancy
  • Infant Development and Preterm Care
  • Blood transfusion and management
  • Migration, Identity, and Health
  • Pelvic floor disorders treatments
  • Endometriosis Research and Treatment
  • HIV-related health complications and treatments
  • Breastfeeding Practices and Influences

Hôpital Paris Saint-Joseph
2015-2024

Inserm
2015-2024

Université Paris Cité
2015-2024

Centre de Recherche Épidémiologie et Statistique
2015-2024

Sorbonne Paris Cité
2015-2024

Gouvernance, Risque, Environnement, Développement
2024

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
2021-2024

Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine
2024

Université de Bordeaux
2020-2023

Saint Joseph Hospital
2018-2023

Caroline Charlier Élodie Perrodeau Alexandre Leclercq B. Cazenave Benoît Pilmis and 95 more Benoît Henry Amanda Lopes Mylène M. Maury Alexandra Moura François Goffinet Hélène Dieye Pierre Thouvénot Marie‐Noëlle Ungeheuer Mathieu Tourdjman V. Goulet Henriette de Valk Olivier Lortholary Philippe Ravaud Marc Lecuit Pierre Hausfater Jean-Louis Pourriat Enrique Casalino Bruno Riou Dominique Pateron Patrick Yéni François Bricaire Y. Ville Élie Azria Marc Dommergues Jean‐François Bergmann Michel Wolff Jean‐Paul Mira Loı̈c Guillevin Mathieu Zuber Soumeth Abasse Saïd Aberrane P. Abgueguen Ayman Abokasem Bruno Abraham Chantal Ache-Papillon Pascal Adam M. N. Adam Xavier Adhoute D. Adoué Moncef Afi N. Afroukh Ilhem Agha-Mir Nejla Aissa Liamine Aissaoui G. Akerman Ali Akkari Majed Al Chaar Faraj Al Freijat Bachar Al-Jalaby Didier Albert Marie-Thérèse Albertini Hélène Albinet Gwenaël Alfonsi Youssef Ali Zahr-Eddine Ali Chaouche Anne Allart Laurent Alric Alain Améri Zahir Amoura Alexandre Ampère Hakim Amroun Amévi Ananivi Pascal Ancelin Thierry André Antoine Andremont Dominique Andreotti Hélinoro Andriamaneo Clara Andriau Hélène Anglaret Nadia Anguel Véronique Annaix Wassila Anteur D. Anuset Ourida Aoudia Miloud Arabi Muriel Archambaud M. Archambaud E. Ardiet Laurent Argaud S. Arista Guillaume Arlet Jean Armengaud Jean-Michel Arnal Isabelle Arnault Olivier Arsène Z. Assaf Assi Assi David Assouline Dominique Astruc Y. Aubard Claude Aubert Jean-Paul Aubry Marc Auburtin Philippe Aucher Philippe Audeguy

10.1016/s1473-3099(16)30521-7 article EN The Lancet Infectious Diseases 2017-01-28
Laurent Mandelbrot Roland Tubiana Jérôme Le Chenadec Catherine Dollfus Albert Faye and 95 more E. Pannier Sophie Matheron Marie-Aude Khuong Valérie Garrait Véronique Reliquet Alain Devidas Alain Berrébi C Allisy Christophe Elleau C. Arvieux Christine Rouzioux Josiane Warszawski Stéphane Blanche Laurent Mandelbrot C. Crenn-Hébert Corinne Floch-Tudal Fabienne Mazy Marine Joras Françoise Meier Emmanuel Mortier Pierre‐François Ceccaldi Maïa Banigé Agnès Uludag Virginie Zarouk A. Lefort Gilles Hittinger Jean-Marc Chamouilli Christian Burle Alain Lafeuillade Marie Medus Germaine Bachelard Joëlle Dendale-Nguyen Thomas Guimard Karine Guimard Jean-Pierre Brossier Philippe Van de Perre Jean-Luc Esnault Olivier Bollengier Stragier Sophie Leautez-Nainville Sandrine-Anne Martha Benoît Martha E. Maurel Michel Françoise Muriel Barat Patricia Murger Mahfoud Rouha P Lumbroso A Checoury Pascale Perfezou Gilles Blondin Séverine Ansart Luc de Saint Martin Philippe Le Moine Corinne Daniel Christian Calvez Emmanuelle Boutard C. Arvieux Estelle Bauville Christelle Dupre Yves Poinsignon Anne Grelier Gaétane Mousset Corinne Cudeville Mathilde Niault Isabelle Belzic Philippe Moreau Marie-Françoise Le Coz Odile Luycx Vaillant Virginie Vitrat D. Tardif Jacques Gaillat Anne Vanderbergh Suzanne Braig Marion Dehlinger-Paul Khaled Mohamed Brigitte Heller-Roussin Cécile Winter Ghislaine Firtion E. Pannier Myriam Costa Odile Launay Dominique Salmon Ceron Sophie Matheron Mandovi Rajguru Neila Elaoun Lahcene Allal Élie Azria Agnès Bourgeois Moine Valérie Garrait Isabelle Hau Claudine Touboul Lanto Ratsimbazafy Christiane Kommé Brigitte Elharrar Jean-Marc Labaune

Abstract Background. The efficacy of preventing perinatal transmission (PT) human immunodeficiency virus type 1 (HIV-1) depends on both viral load (VL) and treatment duration. objective this study was to determine whether initiating highly active antiretroviral therapy (ART) before conception has the potential eliminate PT. Methods. A total 8075 HIV-infected mother/infant pairs included from 2000 2011 in national prospective multicenter French Perinatal Cohort (ANRS-EPF) received ART,...

10.1093/cid/civ578 article EN Clinical Infectious Diseases 2015-07-21

The use of tranexamic acid reduces mortality due to postpartum hemorrhage. We investigated whether the prophylactic administration in addition oxytocin women with vaginal delivery would decrease incidence In a multicenter, double-blind, randomized, controlled trial, we randomly assigned labor who had planned singleton live fetus at 35 or more weeks gestation receive 1 g placebo, administered intravenously, after delivery. primary outcome was hemorrhage, defined as blood loss least 500 ml,...

10.1056/nejmoa1800942 article EN New England Journal of Medicine 2018-08-22
Nelly Briand Josiane Warszawski Laurent Mandelbrot Catherine Dollfus E. Pannier and 95 more L. Cravello Rose Nguyen Sophie Matheron Norbert Winer Roland Tubiana Christine Rouzioux Albert Faye Stéphane Blanche Laurent Mandelbrot Françoise Meier Dominique Duro Marine Joras E. Mortier C. Crenn-Hébert Corinne Floch-Tudal Fabienne Mazy M. Bensalah Agnès Villemant-Uludag A. Lefort Virginie Zarrouk Pierre‐François Ceccaldi Gisèle Philip Gilles Hittinger Martine Malet B. Bachelard Marie Medus Joëlle Dendale-Nguyen Jean-Pierre Brossier Olivier Aubry Jean-Luc Esnault S Léautez Philippe Van de Perre Isabelle Suaud Sandrine-Anne Martha Mahfoud Rouha Pascale Perfezou G Blondin Charles Bellot Séverine Ansart Philippe Le Moine Karine Bages-Jaffuel Jean-Charles Duthé M. Garrè S. Jaffuel Corinne Daniel Christian Calvez C. Beuscart Emmanuelle Boutaric Jennifer Rohan Sylvie Lemoal L. Lassel Ghislaine Cotten Caroline Dupré Esther Beauville C. Arvieux Anabèle Dos Santos Corinne Cudeville Yves Poinsignon Virginie Mouton-Rioux Gaétane Mousset Anne Grellier Philippe Moreau Philippe Tillaut Virginie Mouton-Rioux Odile Luycx-Vaillant Philippe De Morel Marie-Françoise Le Coz Isabelle Belzic M. Niault Anne Vandenbergh C. Janssen Suzanne Braig Virginie Vitrat J. Gaillat Gaëlle Clavere J.P. Bru Blandine Peyret Catherine Mullard Marie Echard Philippe Talon Marjorie Dehlinger Cécile Winter Brigitte Heller-Roussin Odile Launay M Fouchet Ghislaine Firtion Isabelle Goupil E. Pannier Nora Boudjoudi Agnès Bourgeois-Moine M Bodard Valérie Vivier Mandovi Rajguru Virginie Huri Élie Azria

Intrapartum intravenous zidovudine (ZDV) prophylaxis is a long-standing component of prevention mother-to-child transmission (MTCT) human immunodeficiency virus (HIV) in high-resource countries. In some recent guidelines, ZDV no longer systematically recommended for mothers receiving combination antiretroviral therapy (cART) with low viral load. We evaluated the impact according to load and obstetrical conditions. All HIV-1-infected women delivering between 1 January 1997 31 December 2010...

10.1093/cid/cit374 article EN Clinical Infectious Diseases 2013-05-31

Umbilical cord blood from healthy neonates with no known infectious exposure contains T cells an effector memory–like phenotype.

10.1126/scitranslmed.3008748 article EN Science Translational Medicine 2014-05-28

OBJECTIVE: To evaluate the association between planned mode of delivery and neonatal mortality morbidity in an unselected population women with twin pregnancies. METHODS: The JUmeaux MODe d'Accouchement (JUMODA) study was a national prospective population-based cohort study. All pregnancies their neonates born at or after 32 weeks gestation cephalic first were recruited 176 maternity units France from February 2014 to March 2015. primary outcome composite intrapartum morbidity. Comparisons...

10.1097/aog.0000000000002048 article EN Obstetrics and Gynecology 2017-05-09

To assess neonatal morbidity in twin pregnancy according to the planned mode of delivery.A retrospective cohort study 758 consecutive sets twins born after 35 weeks gestation with a cephalic-presenting first was undertaken level III maternity unit which active management second delivery is performed routinely. The primary outcome composite measure mortality and morbidity, including pH less than 7.0, 5-minute Apgar score 4, intensive care transfer more 4 days, pneumothorax, fracture. Control...

10.1097/aog.0b013e318163c435 article EN Obstetrics and Gynecology 2008-03-01

The first reports on the pandemic influenza 2009 A/H1N1v from USA, Mexico, and Australia indicated that this disease was associated with a high mortality in pregnant women. aim of study to describe compare characteristics severe critically ill non-severe women A/H1N1v-related illness France.A national registry created screen laboratory-confirmed influenza. Three hundred fifteen patients 46 French hospitals were included: 40 admitted intensive care units (severe outcomes), 111 hospitalized...

10.1371/journal.pone.0013112 article EN cc-by PLoS ONE 2010-10-05

To assess whether outpatient cervical ripening at 41 0/7 weeks of gestation with the nitric oxide donor isosorbide mononitrate reduces cesarean delivery rates in nulliparous women an unfavorable cervix.We recruited pregnant a Bishop score less than 6 randomized, multicenter, double-blind, placebo-controlled trial. Women received 40 mg vaginal or placebo 0/7, 2/7, and 4/7 gestation. They returned home between visits. At 5/7 gestation, for who had not yet given birth, labor was induced...

10.1097/aog.0000000000000544 article EN Obstetrics and Gynecology 2014-11-07
Clément Taron-Brocard Jérôme Le Chenadec Albert Faye Catherine Dollfus Tessa Goetghebuer and 95 more Vincent Gajdos Jean-Marc Labaune Anaïs Perilhou Laurent Mandelbrot Stéphane Blanche Josiane Warszawski Laurent Mandelbrot C. Crenn-Hébert Corinne Floch-Tudal Fabienne Mazy Marine Joras Françoise Meier E. Mortier Pierre‐François Ceccaldi Maïa Banigé Agnès Uludag Virginie Zarouk A. Lefort Gilles Hittinger J.-M. Chamouilli Christian Burle Alain Lafeuillade M. Médus Gastón Bachelard Joëlle Dendale-Nguyen Thomas Guimard Karine Guimard Jacques Brossier Philippe Van de Perre J.-L. Esnault Olivier Bollengier Stragier Sophie Leautez-Nainville Sandrine Anne Martha B. Martha E. Maurel M Françoise M. Barat Patricia Murger Mahfoud Rouha P Lumbroso A Checoury Pascale Perfezou G Blondin Séverine Ansart Luc de Saint Martin Philippe Le Moine C Daniel Christian Calvez Emmanuelle Boutard C. Arvieux Estelle Bauville Caroline Dupré Yves Poinsignon Aurore Grelier Gaétane Mousset Corinne Cudeville M. Niault Isabelle Belzic Philippe Moreau Marie Francoise Le Coz O. Vaillant Virginie Vitrat D. Tardif J. Gaillat Anne Vanderbergh Suzanne Braig M. Dehlinger-Paul Kamal A. Mohamed Brigitte Heller-Roussin Cécile Winter Ghislaine Firtion E. Pannier Maria Laura Costa Odile Launay Dominique Salmon Ceron Sophie Matheron M. Rajguru Neila Elaoun Lahcene Allal Élie Azria Agnès Bourgeois Moine Valérie Garrait Isabelle Hau Cyril Touboul Lanto Ratsimbazafy Christiane Kommé Brigitte Elharrar Jean-Marc Labaune Laurent Cotte R.-C. Rudigoz Christophe Elleau C. Runel-Belliard T. Pistone Blandine Muanza E. Broustal

Background. Morbidity and mortality are higher among human immunodeficiency virus (HIV) exposed but uninfected (HEU) infants than unexposed infants, particularly if the mother had a low CD4 count. We investigated possible association between maternal immune depression during pregnancy risk of infection in HEU national French Perinatal Cohort (EPF). Methods. All neonates, born alive, to HIV-1–infected women enrolled EPF 2002 2010 were included. The primary outcome was first serious...

10.1093/cid/ciu586 article EN Clinical Infectious Diseases 2014-07-22

Objective Because the effectiveness of antenatal care in reducing pregnancy complications is still discussed despite widespread recommendations its use, we sought to assess association between utilisation recommended and severe maternal ( SMM ) perinatal morbidity SPM ). Design Prospective cohort study. Setting Four maternity units around Paris 2010–2012. Sample 9117 women with singleton pregnancies. Methods Logistic regression models adjusted for social, demographic medical characteristics....

10.1111/1471-0528.14794 article EN BJOG An International Journal of Obstetrics & Gynaecology 2017-06-20

Maternal social deprivation is associated with an increased risk of adverse maternal and perinatal outcomes. Inadequate prenatal care utilization (PCU) likely to be important intermediate factor. The health system in France provides essential services all pregnant women irrespective their socioeconomic status. Our aim was assess the association between PCU. analysis performed database multicenter prospective PreCARE cohort study. population source consisted parturient registered for delivery...

10.1186/s12884-017-1310-z article EN cc-by BMC Pregnancy and Childbirth 2017-04-25

In infants, the mode of acquisition CC17 group B Streptococcus (GBS), hypervirulent clone responsible for late-onset disease (LOD), remains elusive.In a prospective multicenter study in France, we evaluated GBS colonization mother-baby pairs with 2 months follow-up between 2012 and 2015. Criteria included positivity at antenatal screening or delivery. Maternal vaginal samples infant oral cavity stool were analyzed delivery, 21 ± 7 days (D21), 60 (D60) post-delivery.A total 890 analyzed....

10.1093/cid/ciz033 article EN Clinical Infectious Diseases 2019-01-23

Abstract This study aimed to identify the risk factors for placenta accreta spectrum (PAS) in women who had at least one previous cesarean delivery and a previa or low-lying. The PACCRETA prospective population-based took place 12 regional perinatal networks from 2013 through 2015. All with more prior cesareans low lying were included. Placenta was diagnosed according standardized clinical histological criteria. Of 520,114 deliveries, 396 fulfilled inclusion criteria; 108 classified PAS...

10.1038/s41598-024-56964-9 article EN cc-by Scientific Reports 2024-03-19
Coming Soon ...